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Objectives: historically infrainguinal reconstruction using heterogenous grafts has given poor results due to degradation
and aneurysmal dilatation of the graft. A recently introduced heterogenous graft, the ProCol (bovine mesenteric vein) graft,
may yield improved results. There are no published reports with respect to ProCol in infrainguinal reconstruction and hence
we have reviewed our initial experience with this graft.
Methods: retrospective analysis of six patients in whom infrainguinal reconstruction with ProCol was undertaken between
March and August 2001.
Results: the primary patency rate was 0% at 3 months, with grafts failing between 4 and 113 days. Two grafts underwent
aneurysmal dilatation.
Conclusion: we are unable to recommend use of the ProCol graft in infrainguinal reconstruction.
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Introduction
The use of alternative biological materials, in prefer-
ence to prosthetic, is conceptually advantageous in
infrainguinal reconstruction when autologous vein is
not available. Heterogenous grafts have however
proved disappointing in this respect. It has been sug-
gested that a recently introduced graft, the ProCol glu-
teraldehyde tanned bovine mesenteric vein graft
(Hancock Jaffe Laboratories, CA, U.S.A.), may yield bet-
ter results [Oztekin OTO, Sariosmanoglu N, Ccikel U,
Hazan E, Catalyurek H, Sillstrell E, Early experience
with ProCol (bovine mesenteric vein) Vascular Bio-
prosthesis in infrainguinal arterial reconstructions].
To date there are no published results looking at the
use of ProCol grafts in infrainguinal reconstruction.
In the absence of such data we have reviewed our
initial experiences with this graft.
Materials and Methods
Six patients (three male, age range 53±78 years) at
our institution underwent infrainguinal arterial
reconstruction with ProCol between March and
August 2001. ProCol was used where autologous
vein would have been the conduit of choice but was
unavailable. The graft was used in accordance with
the manufacturer's guidelines.
Five patients had Fontaine stage III limb ischaemia
and one Fontaine stage IV. Four of the six had under-
gone previous infrainguinal reconstructive surgery.
Two grafts were anastamosed to the suprageniculate
popliteal artery, one was an interposition graft, one to
the infrageniculate popliteal artery and two onto crural
vessels. Pre-operative investigations had demon-
strated satisfactory distal run off in all six patients,
and intra-operative quality control with Doppler ultra-
sound was satisfactory in all cases. Postoperatively all
patients were entered into a graft surveillance program.
Retrospective analysis of the six reconstructions
was performed with patient interview, examination
and review of the notes.
Results
All six ProCol grafts implanted have failed. This
occurred from 4 to 113 days post operatively and
was confirmed by arterial duplex scanning. The
mechanism of failure was thrombosis in five patients,
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whilst one failed secondary to aneurysmal dilatation.
In one case of graft failure secondary to thrombosis
there was immediate aneurysmal dilatation of the
graft on perfusion. This was related to a venous
tributary and was corrected at the time. In all two
out of the six grafts underwent dilatational changes
after implantation.
The graft that failed secondary to aneurysmal
dilatation was biopsied and a cross section of this is
shown in Figure 1. This shows marked giant cell
infiltration but no evidence of acute infection in the
graft material.
Discussion
Our initial experience with ProCol in infrainguinal
reconstruction yielded a primary patency rate of 0%,
and whilst not the subject of a formal randomised
controlled trial, this is at considerable variance with
our audited and expected outcome for this type of
reconstruction.
Autologous long saphenous vein is unavailable or
unsuitable for use in approximately 30% of patients.1
Historically, the search for a vein substitute has fol-
lowed two main paths. One of these involved the use
of umbilical vein allograft, and was particularly
popular in the late 1980s.2 Although initial patency
rates were promising,3 umbilical vein was found to
be subject to a high incidence of graft degradation and
aneurysm formation.4,5
The second alternative was the use of heterogenous
graft. An example of this was the modified bovine
carotid artery graft, first used in 1963. This was again
abandoned as a result of the high aneurysmal dilata-
tion rate.6 Unfortunately, further attempts using heter-
ogenous grafts have likewise yielded poor long term
results due to degeneration and aneurysmal changes,
and have since fallen out of favour.7,8 One hetero-
genous graft, the BioPolyMeric graft (St Jude Medical
Inc., MN, U.S.A.), appeared initially to yield good
long term patency rates.9 However, all reconstructions
reported were suprageniculate, for which most would
use PTFE as the preferred conduit in the absence of
vein. The incidence of graft dilatation may also have
been under reported in this study as angiography was
used for graft surveillance, which is less sensitive than
duplex scanning for detecting aneurysmal disease.10
Our initial experience with ProCol in infrainguinal
reconstruction has been very disappointing, and we
have ceased implanting this graft. We are unable to
recommend ProCol graft for arterial reconstruction in
the lower limb.
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